In fact, mice treated with LNPs generating CAR-Ms as well as CD24-Siglec-G blockade are able to augment the phagocytic function of liver macrophages, reduce tumour burden and increase the survival of mice subjected to an orthotopic HCC model. Here, CD24 is linked to hepatocellular carcinoma.